FalkE. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation1985;71:699–708
2.
MarcusADewoodSporesJ. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.N Engl J Med1980;303:897–902
3.
MizunoKSatomuraKMiyamotoA. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes.N Engl J Med1992;326:287–292
4.
KaartinenMPenttiläAKovanenPt. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture.Circulation1994;90:1669–1678
5.
GuytonJrKlempKf. Development of the atherosclerotic core region. Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta.Arteriosclerosis Thrombosis1994;14:1305–1314
6.
ChengGcLoreeUmKammRd. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation.Circulation1993;87:1179–1187
7.
FernáNdez-OrtizABadimonJjFalkE. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture.J Am Coll Cardiol1994;23:1562–1569
8.
The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.N Engl J Med1993;329:673–682
9.
The GUSTO Angiographic Investigators. The comparative effects of tpa, streptokinase, or both on coronary artery patency, ventricles function, and survival after myocardial infarction.N Engl J Med1993;329:1615–1622
10.
ElisSgTopolEjGeorgeBs. Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator.Circulation1989;80:1159–1165
11.
EllisSgDeboweyDBatesErTopolEj., Treatment of recurrent ischemia after thrombolysis and successful reperfusion for acute myocardial infarction: effect on in-hospital mortality and left ventricular function.J Am Coll Cardiol1991;17:752–757
12.
ReinerJsLunderganCfVan Den BrandM. Early angiography cannot predict postthrombolytic coronary re-occlusion: observations from the GUSTO Angiographic Study.J Am Coll Cardiol1994;24:1439–1444
13.
OhmanEmGeorgeBsWhiteCj. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial.Circulation1994;90:792–799
14.
National Heart Attack Alert Program.U.S. Department of Health and Human services. UIH Publication Number 93–3278, 1993
15.
ItoHTomookaTSakaiN. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterio myocardial infarction.Circulation1992;85:1699–1705
16.
BeckerRcBovillEgCorraoJmfor the TIMI III Thrombosis and Coagulation Group.. Platelet activation determined by flow cytometry persists despite antithrombotic therapy in patients with unstable angina and non-Q wave myocardial infarction.J Thrombosis Thrombolysis1994;1:95–100
17.
OhmanEmCaliffRmTopolEj. Consequences of reocclusion after success reperfusion therapy in acute myocardial infarction.Circulation1990;82:781–791
18.
DalenJeGoreJmBraunwaldE. Six- and twelvemonth follow-up of the Phase I thrombolysis in myocardial infarction (TIMI) trial.Am J Cardiol1988;62:179–185
19.
MeijerAVerheugtFwaWerterCjpj. Aspirin versus Coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT study.Circulation1993;87:1524–1530
20.
VeenGMeyerAVerheugtFwa. Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study.J Am Coll Cardiol1993;22:1755–1762
21.
RouxSChristellerSLÜDinE. Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis.J Am Coll Cardiol1992;19:671–677
22.
LonnEmYusufSJhaP. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.Circulation1994;90:2056–2069
23.
PfefferMaLamasGaVaughanDe. Effect of captopril on progressive ventricular dilation after anterior myocardial infarction.N Engl J Med1988;319:80–86
24.
PfefferMaBraunwaldEMoyéLa. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial.N Engl J Med1992;327:669–684
25.
YusufSPepineCjGarcesC. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.Lancet1992;340:1173–1178
26.
EllisSgDa SilvaErHeyndrickxG. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction.Circulation1994;90:2280–2284
27.
BeckerRcCharlesworthAHamptonJ. Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (late) study.J Am Coll Cardiol1995;25:1063–1068